Bankrupt PhaseBio Pharma Finds Buyers for Secondary Assets After Auction -- Market Talk
1601 ET - Publicly traded PhaseBio Pharmaceuticals, which has already reached a deal to sell its key drug program during its bankruptcy, says it has also found proposed buyers for its secondary assets
SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets From PhaseBio Pharmaceuticals
SFJ Pharmaceuticals ("SFJ" or the "company") today announced the closing of the sale and transfer of assets related to Bentracimab from PhaseBio Pharmaceuticals, Inc. ("PhaseBio") to SFJ. The sale and transfer was
Delisting of Securities of PhaseBio Pharmaceuticals, Inc.; Zovio Inc.; Fast Radius, Inc.; and Kismet Acquisition Three Corp. From The Nasdaq Stock Market
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc.'s common stock was suspended on
PhaseBio Pharmaceuticals (NASDAQ:PHAS) Trading Up 7%
PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS – Get Rating) shares were up 7% during trading on Wednesday . The stock traded as high as $0.11 and last traded at $0.10. Approximately 455,938 shares chan
Bankrupt PhaseBio Identifies Chiesi as Lead Bidder for Bentracimab Assets
By Becky Yerak Chiesi Farmaceutici SpA has been named as the lead bidder for the key assets of PhaseBio Pharmaceuticals Inc., a publicly traded drug developer that is in chapter 11 bankruptcy. Phase
Express News | News On PhaseBio Pharmaceuticals Inc. (PHAS) Now Under PHASQ
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.Arcturus Therapeutics (NASDAQ:ARCT
Head to Head Analysis: PhaseBio Pharmaceuticals (NASDAQ:PHAS) Vs. Alpine Immune Sciences (NASDAQ:ALPN)
PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Rating) and Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the
Head-To-Head Contrast: Alpine Immune Sciences (NASDAQ:ALPN) Vs. PhaseBio Pharmaceuticals (NASDAQ:PHAS)
Alpine Immune Sciences (NASDAQ:ALPN – Get Rating) and PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the
PhaseBio Pharmaceuticals Shares Are Trading Lower After the Company Reported It Received Notice From Nasdaq Stating It Has Determined That the Company's Securities Will Be Delisted From Nasdaq.
PhaseBio Pharmaceuticals shares are trading lower after the company reported it received notice from Nasdaq stating it has determined that the company's securities will be delisted from Nasdaq.
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Abiomed (NASDAQ:ABMD) shares increased by 50.3% to $378.91 during Tuesday's regular session. As of 13:30 EST, Abiomed's stock is trading at a volume of 5.0 million, which is 1802.3% of its ave
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 85 stocks hit new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Mobileye Global (NASDAQ:MBLY).First Wave BioP
Wall Street Set to Open Higher Ahead of Manufacturing PMI, Fed Meeting
09:10 AM EDT, 11/01/2022 (MT Newswires) -- U.S. stocks look set to open Tuesday higher as investors look to extend October's winning streak into November, and ahead of the manufacturing PMI reading la
Top Premarket Gainers
07:29 AM EDT, 11/01/2022 (MT Newswires) -- Abiomed (ABMD) shares surged nearly 52% premarket Tuesday after it agreed to be acquired by Johnson & Johnson (JNJ) for $380 in cash per share, represent
Why Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Gainers Quotient Limited (NASDAQ:QTNT) rose 60.7% to $0.1295 in pre-market trading. Quotient shares dipped 37% on Monday after the company announced a 1-for-40 reverse stock split.PhaseBio Pharmaceuti
PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq
PhaseBio Pharmaceuticals Says On Oct. 25, 2022 Co. Received Notice From Nasdaq Stating It Has Determined That Co.'s Securities Will Be Delisted From Nasdaq
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Aeglea BioTherapeutics (NASDAQ:AGLE) shares rose 53.4% to $0.87 during Friday's regular session. Trading volume for this security as of 13:30 EST is 25.1 million, which is 1291.9% of its avera
Stocks That Hit 52-Week Lows On Friday
During Friday, 125 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the biggest company by market cap to set a new 52-week low.Vallon Pharmace
Enterprise Associates 13 L. New Sells 1,784,109 Shares of PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) Stock
PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS – Get Rating) major shareholder Enterprise Associates 13 L. New sold 1,784,109 shares of the firm's stock in a transaction dated Tuesday, October 25th. The
Why Skechers Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
Gainers Ensysce Biosciences, Inc. (NASDAQ:ENSC) rose 53.5% to $0.32 in pre-market trading after gaining 13% on Tuesday.Cosmos Holdings Inc. (NASDAQ:COSM) shares rose 22.7% to $0.1071 in pre-market tra
No Data